South Asia
-
India’s AU Financiers has filed a draft prospectus for its IPO, offering only secondary shares in a deal slated for the first half of this year. -
A $1.75bn borrowing for Indian conglomerate Reliance Industries has been opened into general syndication with a 19-strong banking group at the top.
-
India will give a fillip to its treasury by raising Rp110bn ($1.63bn) from the listing of state-owned insurance companies, according to the national budget.
-
UniCredit has made three senior appointments in Asia, including to its management in Singapore and Mumbai, as well as hiring Florence Blazy as a senior banker in France.
-
Indian finance minister Arun Jaitley plans to continue the government’s disinvestment programme in the new financial year beginning in April, with IPOs of some state-owned railway companies on the cards.
-
The Securities and Exchange Board of India has issued a circular attempting to smooth the process of cross listing of bourses, just days after the Bombay Stock Exchange sealed its IPO.
-
France’s €7bn green OAT is a cert for the awards ceremonies. But are investors in it really helping the environment?
-
Few Indian IPOs can boast of having $6.4bn in excess demand, but BSE is one of them. The Bombay stock exchange operator completed bookbuilding for its Rp12.4bn ($182m) float this week, an extraordinary end to a sale first mooted over a decade ago. The pressure is now on its larger rival to do just as well, writes John Loh.
-
Indian power company NTPC made its debut in the euro market on Wednesday with a €500m deal, seeking out the currency to take advantage of favourable interest rates.
-
ANZ names new Oz loan syndications head — SBI Capital Markets, CIMB India lose ECM bankers — JP Morgan hires for China research
-
A recent spate of high profile loans has shown that Indian banks have the ability to execute highly structured M&A funding. This has reignited gripes about rules that bar Indian lenders from funding acquisitions of domestic companies, hindering the growth of small borrowers with big ambitions. Shruti Chaturvedi reports.
-
A dual currency financing to back Indian company Intas Pharmaceuticals’ acquisition of a portfolio of assets in the UK and Ireland has netted $650m-$670m of commitments.
